Skip to main content

MIT Protein Lab to Close upon Peter Kim s Departure, Forbes.com Says

NEW YORK, Dec 12 – A 20-person protein research group at the Whitehead Institute is scheduled to close after the group's leader, Peter S. Kim, takes up a new post at Merck, Forbes.com said on Monday.

“After he’s made sure that all his students have places to go, his lab at MIT’s Whitehead will close,” the on-line news service said.

A spokeswoman for the institute did not return calls seeking comment.

Peter Kim, a renowned proteomics experts, has been hired to head Merck’s research operations. The move was seen as signaling the pharmaceutical giant’s increased efforts to strengthen its proteomics initiative.

Kim is the principle investigator for a group at the Whitehead Institute that studies protein-protein interactions as well as biological process within proteins. He is also a member of the NIH’s AIDS Vaccines Research Committee.

Kim will eventually replace Edward Scolnick, Merck’s current research chief. In the meanwhile he will report to Scolnick and head the company’s internal drug discovery and development.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.